Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression
Author(s) -
Mauricio Tohen,
Eduard Vieta,
Joseph R. Calabrese,
Terence A. Ketter,
Gary Sachs,
Charles L. Bowden,
Philip B. Mitchell,
Franca Centorrino,
Richard C. Risser,
Robert W. Baker,
Angela R. Evans,
Karin Beymer,
Sanjay Dubé,
Gary D. Tollefson,
Alan Breier
Publication year - 2003
Publication title -
archives of general psychiatry
Language(s) - English
Resource type - Journals
eISSN - 1538-3636
pISSN - 0003-990X
DOI - 10.1001/archpsyc.60.11.1079
Subject(s) - olanzapine , fluoxetine , mania , young mania rating scale , placebo , psychology , randomized controlled trial , psychiatry , mood stabilizer , bipolar disorder , medicine , depression (economics) , mood , schizophrenia (object oriented programming) , receptor , alternative medicine , pathology , serotonin , economics , macroeconomics
Despite the longer duration of the depressive phase in bipolar disorder and the frequent clinical use of antidepressants combined with antipsychotics or mood stabilizers, relatively few controlled studies have examined treatment strategies for bipolar depression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom